EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

The Role of Tranexamic Acid in Managing Traumatic Hemorrhage: A Review of Current Evidence

Aleksandra Makulec, Aleksandra Szredzka, Katarzyna Otrębska, Dominika Lewandowska, Aleksandra Jóźwik-Szymańska, Natalia Kostecka, Laura Mikuła, Zuzanna Bogdan-Groszyk, Jan Kucharski, Helena Muszyńska

Quality in Sport · 26.04.2026 · 54 · 70843

DOI: 10.12775/qs.2026.54.70843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 26.04.2026. Verfasst von Aleksandra Makulec und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Traumatic hemorrhage is one of the leading causes of death among patients with severe injuries. Tranexamic acid (TXA), a synthetic antifibrinolytic agent, has shown potential to reduce massive blood loss and decrease mortality.

Aim

The aim of this study was to analyze current evidence regarding the efficacy and safety of tranexamic acid in the treatment of traumatic hemorrhage and to assess the factors influencing its therapeutic effect.

Methods

A literature review was conducted covering publications (2010-2026), including clinical studies, randomized controlled trials, systematic reviews, and meta-analyses concerning the use of TXA in trauma patients. Data on the timing and route of administration, dosing, efficacy, and safety of therapy were analyzed.

Results

TXA reduces blood loss and may lower mortality, especially when administered early after injury. Intravenous use is standard, while intraosseous or intramuscular routes may be used prehospital. TXA is generally safe, but monitoring for thromboembolic events and dose-related adverse effects is recommended in patients with multiple injuries.

Conclusions

TXA is an effective and safe option in traumatic hemorrhage management. Its efficacy depends on timing, dosing, and patient factors. Early use improves outcomes, but further research is needed to optimize treatment and assess alternative administration routes.

Zitieren

APA

Makulec, A., Szredzka, A., Otrębska, K., Lewandowska, D., Jóźwik-Szymańska, A., Kostecka, N., Mikuła, L., Bogdan-Groszyk, Z., Kucharski, J., & Muszyńska, H. (2026). The Role of Tranexamic Acid in Managing Traumatic Hemorrhage: A Review of Current Evidence. Quality in Sport, 54, 70843. https://doi.org/10.12775/qs.2026.54.70843

Vancouver

Makulec A, Szredzka A, Otrębska K, Lewandowska D, Jóźwik-Szymańska A, Kostecka N, et al. The Role of Tranexamic Acid in Managing Traumatic Hemorrhage: A Review of Current Evidence. Quality in Sport. 2026;54:70843. doi:10.12775/qs.2026.54.70843

BibTeX
@article{Makulec2026,
  author = {Makulec, Aleksandra and Szredzka, Aleksandra and Otrębska, Katarzyna and Lewandowska, Dominika and Jóźwik-Szymańska, Aleksandra and Kostecka, Natalia and Mikuła, Laura and Bogdan-Groszyk, Zuzanna and Kucharski, Jan and Muszyńska, Helena},
  title = {The Role of Tranexamic Acid in Managing Traumatic Hemorrhage: A Review of Current Evidence},
  journal = {Quality in Sport},
  year = {2026},
  volume = {54},
  pages = {70843},
  doi = {10.12775/qs.2026.54.70843}
}
Kostenlos starten →